These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 16575740)

  • 1. Oropharyngeal candidiasis: a new treatment option.
    Klotz SA
    Clin Infect Dis; 2006 Apr; 42(8):1187-8. PubMed ID: 16575740
    [No Abstract]   [Full Text] [Related]  

  • 2. A multicenter randomized trial evaluating posaconazole versus fluconazole for the treatment of oropharyngeal candidiasis in subjects with HIV/AIDS.
    Vazquez JA; Skiest DJ; Nieto L; Northland R; Sanne I; Gogate J; Greaves W; Isaacs R
    Clin Infect Dis; 2006 Apr; 42(8):1179-86. PubMed ID: 16575739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical case presentations. Oropharyngeal and esophageal candidiasis in HIV disease.
    AIDS Patient Care STDS; 1997 Feb; 11 Suppl 1():S22-5. PubMed ID: 11361748
    [No Abstract]   [Full Text] [Related]  

  • 4. Safety and efficacy of posaconazole in the long-term treatment of azole-refractory oropharyngeal and esophageal candidiasis in patients with HIV infection.
    Vazquez JA; Skiest DJ; Tissot-Dupont H; Lennox JL; Boparai N; Isaacs R
    HIV Clin Trials; 2007; 8(2):86-97. PubMed ID: 17507324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Caspofungin in the treatment of oropharyngeal candidiasis.
    Garbino J; Lew D; Hirschel B; Rohner P
    Int J Clin Pract; 2003 Mar; 57(2):143-4. PubMed ID: 12661800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Posaconazole for azole-refractory candidiasis in patients with HIV infection.
    Winslow DL
    AIDS Alert; 2007 May; 22(5):59-60. PubMed ID: 17577961
    [No Abstract]   [Full Text] [Related]  

  • 7. [Itraconazole in systemic fungal infections. Clinical profile and future trends].
    Fernández Fernández A; Esteban Montero S
    Rev Clin Esp; 1995 Oct; 195 Suppl 3():66-70. PubMed ID: 9441309
    [No Abstract]   [Full Text] [Related]  

  • 8. [Antifungal susceptibility for Candida albicans isolated from AIDS patients with oropharyngeal and esophageal candidiasis: experience with Etest].
    Tapia C; González P; Pereira A; Pérez J; Noriega LM; Palavecino E
    Rev Med Chil; 2003 May; 131(5):515-9. PubMed ID: 12879812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Progressive resistance to fluconazole in a patient with HIV infection and recurrent oropharyngeal candidiasis].
    Corzo Delgado JE; Lozano de León F; Aretio Najarro R; Martín Mazuelos E
    Med Clin (Barc); 1994 Nov; 103(16):639. PubMed ID: 7996928
    [No Abstract]   [Full Text] [Related]  

  • 10. Itraconazole and fluconazole in oropharyngeal candidiasis.
    van der Bijl P; Arendorf TM
    Ann Dent; 1993; 52(2):12-6. PubMed ID: 8267372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Miconazole (Oravig) for oropharyngeal candidiasis.
    Med Lett Drugs Ther; 2010 Nov; 52(1352):95-6. PubMed ID: 21116234
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparison of itraconazole and ketoconazole in HIV-positive patients with oropharyngeal or esophageal candidiasis. Human Immunodeficiency Virus Itraconazole Ketoconazole Project Group.
    de Repentigny L; Ratelle J
    Chemotherapy; 1996; 42(5):374-83. PubMed ID: 8874977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Caspofungin--a new therapeutic option for oropharyngeal candidiasis.
    Garbino J
    Clin Microbiol Infect; 2004 Mar; 10(3):187-9. PubMed ID: 15008939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Fluconazole in oro-pharyngeal candidiasis in retroviral infection (experience in Dakar)].
    Sow PS; Diop BM; Ndiaye I; Faye MA; Coll-Seck AM
    Dakar Med; 1993; 38(1):85-8. PubMed ID: 7882856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of therapeutic response of oropharyngeal and esophageal candidiasis in AIDS with use of a new clinical scoring system: studies with D0870.
    Hood SV; Hollis S; Percy M; Atkinson G; Williams K; Denning DW
    Clin Infect Dis; 1999 Mar; 28(3):587-96. PubMed ID: 10194083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Successful treatment of oro-pharyngo-oesophageal Candida albicans infection after renal transplantation (author's transl)].
    Zazgornik J; Kaiser R; Kopsa H; Schmidt P; Pötzi ; Hruby K
    Mykosen; 1978 Feb; 21(2):33-8. PubMed ID: 345119
    [No Abstract]   [Full Text] [Related]  

  • 17. Azole-resistant oropharyngeal and esophageal candidiasis in patients with AIDS.
    Horn CA; Washburn RG; Givner LB; Peacock JE; Pegram PS
    AIDS; 1995 May; 9(5):533-4. PubMed ID: 7639986
    [No Abstract]   [Full Text] [Related]  

  • 18. A systematic review of the effectiveness of antifungal drugs for the prevention and treatment of oropharyngeal candidiasis in HIV-positive patients.
    Patton LL; Bonito AJ; Shugars DA
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Aug; 92(2):170-9. PubMed ID: 11505264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oropharyngeal candidiasis in patients with AIDS: randomized comparison of fluconazole versus nystatin oral suspensions.
    Pons V; Greenspan D; Lozada-Nur F; McPhail L; Gallant JE; Tunkel A; Johnson CC; McCarty J; Panzer H; Levenstein M; Barranco A; Green S
    Clin Infect Dis; 1997 Jun; 24(6):1204-7. PubMed ID: 9195083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral candidiasis in HIV-infected patients.
    Brawner DL; Hovan AJ
    Curr Top Med Mycol; 1995; 6():113-25. PubMed ID: 8724244
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.